Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

CVS facing lawsuit from six Blue Cross insurers

CVS Health has been accused of overcharging for generic medications in a new lawsuit brought forth by six Blue Cross Blue Shield plans.

Thumbnail

Resuming healthcare procedures comes with new set of concerns

As some states reopen businesses and more Americans will resume visiting their doctors, clinicians are concerned about a second wave of COVID-2 infections, according to a survey of clinical leaders.

Thumbnail

Hydroxychloroquine trial suspended by WHO

The World Health Organization has suspended the trial of the controversial drug hydroxychloroquine due to safety concerns.

Thumbnail

Kaiser Permanente CIO to retire

Dick Daniels, chief information officer and vice president at Kaiser Permanente, announced his decision to retire mid-June.

Thumbnail

More Part D plans will likely offer $35 monthly co-pays for insulin in 2021

More than 1,750 standalone Medicare Part D prescription drug plans and MA plans have applied to offer insulin at a maximum $35 copay for a month’s supply of the drug for the 2021 plan year, CMS announced.

Thumbnail

How private equity is ruining healthcare

The healthcare sector has seen an influx of funding from private equity groups over the last several years, aiding in the contraction of the industry. But has the influence of cash been beneficial for healthcare?

Thumbnail

Apple and Google join forces for COVID-19 contact tracing

Technology companies Apple and Google have teamed up to build an element of contact tracing to aid in the COVID-19 response.

Thumbnail

AstraZeneca ramps up COVID-19 vaccine accessibility with $1B in funding

Biopharmaceutical company AstraZeneca has received more than $1 billion in funding from BARDA for the development, production and delivery of Oxford University's vaccine for COVID-19.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.